← Leaderboards
Cristina Lupu
Oklahoma Medical Research Foundation
$1,451,215
Attributed
$1,451,215
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $351.5K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,451,215 · 5
By mechanism
P20$1,440,563 · 4
M01$10,652 · 1
Top collaborators
No co-investigators on record.
Most similar at Oklahoma Medical Research Foundation
Same institution · by research overlap
- Andrew Scott Weyrich$33,262,388
- Kenneth Mark Coggeshall$14,637,824
- Linda F. Thompson$14,550,182
- Florea Lupu$19,062,937
- Fletcher B Taylor$1,141,454
Others in their field
Top investigators on “Glycosylphosphatidylinositols”
- Shanthini Sockanathan · Johns Hopkins University$8,565,858
- Anant K Menon · University Of Wisconsin Madison$7,893,688
- Channe D Gowda · Georgetown University$5,906,029
- George J Broze · Barnes-Jewish Hospital$5,295,092
- Saul A Villeda · Stanford University$5,138,831
- Zhongwu Guo · Case Western Reserve University$4,507,992
Research focus
GlycosylphosphatidylinositolsIn VivoDetergentsInstitutionBinding ProteinsChargeBlood Coagulation DisordersBinding (Molecular Function)Cell PhysiologyComplexComputer Retrieval Of Information On Scientific Projects DatabaseCenters Of Research ExcellenceC-TerminalDatabasesImmunoaffinity ChromatographyEmbryoEndothelial CellsFactor XFactor XaFundingGene DeletionIn VitroGrantLink
Grant awards (6)
COBRE: OK MED RES FOUND: P3: GPI ANCHORING & TISSUE FACTOR PATHWAY INHIBITOR$351,503
P20 · FY2010 · RR · contact PI
COBRE: OK MED RES FOUND: P3: GPI ANCHORING & TISSUE FACTOR PATHWAY INHIBITOR$271,806
P20 · FY2007 · RR · contact PI
COBRE: OK MED RES FOUND: P3: GPI ANCHORING & TISSUE FACTOR PATHWAY INHIBITOR$281,918
P20 · FY2006 · RR · contact PI
COBRE: OK MED RES FOUND: P3: GPI ANCHORING &TISSUE FACTOR PATHWAY INHIBITOR$278,316
P20 · FY2005 · RR
CONTRIBUTIONS OF GPI ANCHORING TO FUNCTIONS OF TISSUE FACTOR PATHWAY INHIBITOR$10,652
M01 · FY2005 · RR
GPI ANCHORING &TISSUE FACTOR PATHWAY INHIBITOR$257,020
P20 · FY2004 · RR